![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
New study demonstrates advantages of PentaHibe for cryopreservation of T cells
New data published by Haastrup EK. et. al in Transfusion and Apheresis Science1 demonstrates the...
Mixed Oxford/Pfizer vaccine schedules generate robust immune response against COVID-19, finds Oxford-led study
Alternating doses of the Oxford-AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against COVID-19, according...
A ‘Single Dose’ of vaccine sufficient for those already infected with COVID-19, says AIG...
During the second COVID wave when cases were growing exponentially; unfortunately, the vaccination rate took...
Aevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 Antibody
Aevi Genomic Medicine, Inc. announced that it has obtained the right to exercise an exclusive...
Navigating Russia’s Compliance Regulations; Arguably the Most Complex in the World
Russia’s increasing reliance on pharmaceutical-driven healthcare is resulting in a growing consumer demand for drugs...
Lonza and AllCells Join Forces for Global Commercialization of Hematopoietic Primary Cells
Lonza and AllCells have entered into a private label partnership for the manufacture and global...
New Study Findings Show Mixture of DuPont Probiotic Strains and Lactoferrin Reduces Common Cause...
New findings from a Giellepi Health Science Division clinical research trial demonstrates that a mixture...
WuXi AppTec Expands Site in California for Pharmaceutical R&D Services
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company...
Eisai and UCLommence preparations for phase i clinical studies in Alzheimer’s Disease for Novel...
Eisai Co., Ltd and University College London announced that they have commenced preparations for Phase...
ADC Bio secures additional equity round investment
ADC Biotechnology , announces that it has secured additional funding of £2.5 million from existing...